BIOGEN INC. - Significant Ownership

Signature - Title
Biogen Inc. - Michael Dambach, Treasurer
Location
Cambridge, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOGEN INC..

Significant Ownership of BIOGEN INC.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAGE Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share 10.2% $46.2M 6.24M BIOGEN INC. Jan 10, 2025

Schedules 13D/G Reported by BIOGEN INC.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.